See also this year's filing and all EDGAR filings for this company.
PDF Report 0001373707_2014_Tetraphase_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001373707, Tetraphase Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 105,420,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 235,000 |
| 3 | remainder_Assets | 231,000 |
| 4 | LiabilitiesCurrent | 13,191,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 24,471,000 |
| 9 | ResearchAndDevelopmentExpense | 106,615,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 18,271,000 |
| 12 | remainder_NetIncome | -6,906,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 105,886,000 |
| 1 | Liabilities | 13,191,000 |
| 2 | Expenses | 131,086,000 |
| 3 | Revenues | 18,271,000 |
| 4 | StockholdersEquity | 92,695,000 |
| 5 | NetIncome | -119,721,000 |
| 6 | ComprehensiveNetIncome | -119,721,000 |
| 7 | BaseVar | 137,670,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.38 |
| 9 | EconomicCapitalRatio | 2.59 |
Edgar->Model Mapping
Feature Distribution
